165 related articles for article (PubMed ID: 33577643)
21. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
[TBL] [Abstract][Full Text] [Related]
22. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
23. Significant melanocytic lesions in infancy, childhood, and adolescence.
Hoss DM; Grant-Kels JM
Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
[TBL] [Abstract][Full Text] [Related]
25. Targetoid hemosiderotic nevus. A trauma-induced simulator of malignant melanoma.
Tomasini C; Broganelli P; Pippione M
Dermatology; 2005; 210(3):200-5. PubMed ID: 15785047
[TBL] [Abstract][Full Text] [Related]
26. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
27. Important melanocytic lesions in childhood and adolescence.
Roth ME; Grant-Kels JM
Pediatr Clin North Am; 1991 Aug; 38(4):791-809. PubMed ID: 1870906
[TBL] [Abstract][Full Text] [Related]
28. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
29. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
Kelly JW; Crutcher WA; Sagebiel RW
J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481
[TBL] [Abstract][Full Text] [Related]
30. Meyerson Phenomenon as a Component of Melanoma in situ.
Sezer E; Özturk Durmaz E; Çetin E; Şahin S
Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
[TBL] [Abstract][Full Text] [Related]
31. Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH.
Gerami P; Barnhill RL; Beilfuss BA; LeBoit P; Schneider P; Guitart J
Am J Surg Pathol; 2010 Jun; 34(6):816-21. PubMed ID: 20431478
[TBL] [Abstract][Full Text] [Related]
32. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party.
Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ
J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous melanocytic dysplasia and malignant melanoma. A critical review.
Kwittken J
J Med; 1991; 22(1):1-16. PubMed ID: 2072047
[TBL] [Abstract][Full Text] [Related]
34. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
[TBL] [Abstract][Full Text] [Related]
35. Nevomelanocytic atypia detection by in vivo reflectance confocal microscopy.
Vaišnorienė I; Rotomskis R; Kulvietis V; Eidukevičius R; Zalgevičienė V; Laurinavičienė A; Venius J; Didžiapetrienė J
Medicina (Kaunas); 2014; 50(4):209-15. PubMed ID: 25458957
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of premalignant melanocytic proliferations.
Sagebiel RW
Pathology; 1985 Apr; 17(2):285-90. PubMed ID: 4047733
[TBL] [Abstract][Full Text] [Related]
37. Histologic spectrum of melanocytic nevi removed from patients > 60 years of age.
Martinka M; Bruecks AK; Trotter MJ
J Cutan Med Surg; 2007; 11(5):168-73. PubMed ID: 17942026
[TBL] [Abstract][Full Text] [Related]
38. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
40. Epidermolysis bullosa nevus: an exception to the clinical and dermoscopic criteria for melanoma.
Cash SH; Dever TT; Hyde P; Lee JB
Arch Dermatol; 2007 Sep; 143(9):1164-7. PubMed ID: 17875878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
